199 related articles for article (PubMed ID: 21204914)
1. Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren.
Tapaninen T; Neuvonen PJ; Niemi M
Br J Clin Pharmacol; 2011 May; 71(5):718-26. PubMed ID: 21204914
[TBL] [Abstract][Full Text] [Related]
2. Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren.
Tapaninen T; Neuvonen PJ; Niemi M
Clin Pharmacol Ther; 2010 Sep; 88(3):339-42. PubMed ID: 20664534
[TBL] [Abstract][Full Text] [Related]
3. Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects.
Rebello S; Zhao S; Hariry S; Dahlke M; Alexander N; Vapurcuyan A; Hanna I; Jarugula V
Eur J Clin Pharmacol; 2012 May; 68(5):697-708. PubMed ID: 22124880
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren.
Tapaninen T; Neuvonen PJ; Niemi M
Eur J Clin Pharmacol; 2010 May; 66(5):497-502. PubMed ID: 20179914
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren.
Tapaninen T; Backman JT; Kurkinen KJ; Neuvonen PJ; Niemi M
J Clin Pharmacol; 2011 Mar; 51(3):359-67. PubMed ID: 20400651
[TBL] [Abstract][Full Text] [Related]
6. Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M; Komori H; Saito S; Kusuhara H; Tamai I; Ieiri I; Uno T; Yasui-Furukori N
Eur J Clin Pharmacol; 2014 Sep; 70(9):1087-95. PubMed ID: 24903351
[TBL] [Abstract][Full Text] [Related]
7. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
[TBL] [Abstract][Full Text] [Related]
8. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.
Shirasaka Y; Shichiri M; Mori T; Nakanishi T; Tamai I
J Pharm Sci; 2013 Sep; 102(9):3418-26. PubMed ID: 23794501
[TBL] [Abstract][Full Text] [Related]
9. Apple juice greatly reduces systemic exposure to atenolol.
Jeon H; Jang IJ; Lee S; Ohashi K; Kotegawa T; Ieiri I; Cho JY; Yoon SH; Shin SG; Yu KS; Lim KS
Br J Clin Pharmacol; 2013 Jan; 75(1):172-9. PubMed ID: 22574741
[TBL] [Abstract][Full Text] [Related]
10. Effects of orange juice on the pharmacokinetics of atenolol.
Lilja JJ; Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):337-40. PubMed ID: 15983823
[TBL] [Abstract][Full Text] [Related]
11. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
[TBL] [Abstract][Full Text] [Related]
12. Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects.
Vaidyanathan S; Jermany J; Yeh C; Bizot MN; Camisasca R
Br J Clin Pharmacol; 2006 Dec; 62(6):690-8. PubMed ID: 17118124
[TBL] [Abstract][Full Text] [Related]
13. SLCO2B1 c.935G>A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren.
Tapaninen T; Karonen T; Backman JT; Neuvonen PJ; Niemi M
Pharmacogenet Genomics; 2013 Jan; 23(1):19-24. PubMed ID: 23151832
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus.
Zhao C; Vaidyanathan S; Yeh CM; Maboudian M; Armin Dieterich H
Clin Pharmacokinet; 2006; 45(11):1125-34. PubMed ID: 17048976
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption.
Shirasaka Y; Shichiri M; Murata Y; Mori T; Nakanishi T; Tamai I
Drug Metab Dispos; 2013 Mar; 41(3):615-21. PubMed ID: 23264447
[TBL] [Abstract][Full Text] [Related]
16. The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans.
Imanaga J; Kotegawa T; Imai H; Tsutsumi K; Yoshizato T; Ohyama T; Shirasaka Y; Tamai I; Tateishi T; Ohashi K
Pharmacogenet Genomics; 2011 Feb; 21(2):84-93. PubMed ID: 21280267
[TBL] [Abstract][Full Text] [Related]
17. Influence of body weight and gender on the pharmacokinetics, pharmacodynamics, and antihypertensive efficacy of aliskiren.
Jarugula V; Yeh CM; Howard D; Bush C; Keefe DL; Dole WP
J Clin Pharmacol; 2010 Dec; 50(12):1358-66. PubMed ID: 20150520
[TBL] [Abstract][Full Text] [Related]
18. Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren.
Tapaninen T; Neuvonen PJ; Niemi M
Eur J Clin Pharmacol; 2010 Sep; 66(9):865-70. PubMed ID: 20496145
[TBL] [Abstract][Full Text] [Related]
19. Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol.
Lilja JJ; Juntti-Patinen L; Neuvonen PJ
Clin Pharmacol Ther; 2004 Mar; 75(3):184-90. PubMed ID: 15001969
[TBL] [Abstract][Full Text] [Related]
20. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.
Shirasaka Y; Shichiri M; Mori T; Nakanishi T; Tamai I
J Pharm Sci; 2013 Jan; 102(1):280-8. PubMed ID: 23132664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]